These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35891800)

  • 41. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.
    Hassan M; Kjos M; Nes IF; Diep DB; Lotfipour F
    J Appl Microbiol; 2012 Oct; 113(4):723-36. PubMed ID: 22583565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens.
    Le MN; Kawada-Matsuo M; Komatsuzawa H
    Front Microbiol; 2022; 13():930629. PubMed ID: 35756032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of antimicrobial peptides in host defense against mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2008 Oct; 29(10):1836-41. PubMed ID: 18582513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-mycobacterial peptides: from human to phage.
    Teng T; Liu J; Wei H
    Cell Physiol Biochem; 2015; 35(2):452-66. PubMed ID: 25613372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The characteristics and roles of antimicrobial peptides as potential treatment for antibiotic-resistant pathogens: a review.
    Zainal Baharin NH; Khairil Mokhtar NF; Mohd Desa MN; Gopalsamy B; Mohd Zaki NN; Yuswan MH; Muthanna A; Dzaraly ND; Abbasiliasi S; Mohd Hashim A; Abdullah Sani MS; Mustafa S
    PeerJ; 2021; 9():e12193. PubMed ID: 35003909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimicrobial Peptides and Their Biomedical Applications: A Review.
    Min KH; Kim KH; Ki MR; Pack SP
    Antibiotics (Basel); 2024 Aug; 13(9):. PubMed ID: 39334969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides.
    Nuri R; Shprung T; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3089-100. PubMed ID: 26051126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insect Antimicrobial Peptides, a Mini Review.
    Wu Q; Patočka J; Kuča K
    Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30413046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools.
    Di Luca M; Maccari G; Nifosì R
    Pathog Dis; 2014 Apr; 70(3):257-70. PubMed ID: 24515391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial peptides of the vaginal innate immunity and their role in the fight against sexually transmitted diseases.
    Madanchi H; Shoushtari M; Kashani HH; Sardari S
    New Microbes New Infect; 2020 Mar; 34():100627. PubMed ID: 31993204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fish antimicrobial peptides (AMP's) as essential and promising molecular therapeutic agents: A review.
    Shabir U; Ali S; Magray AR; Ganai BA; Firdous P; Hassan T; Nazir R
    Microb Pathog; 2018 Jan; 114():50-56. PubMed ID: 29180291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial Peptides: An Approach to Combat Resilient Infections.
    Parai D; Dey P; Mukherjee SK
    Curr Drug Discov Technol; 2020; 17(4):542-552. PubMed ID: 31250760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The resumption of consumption -- a review on tuberculosis.
    Ducati RG; Ruffino-Netto A; Basso LA; Santos DS
    Mem Inst Oswaldo Cruz; 2006 Nov; 101(7):697-714. PubMed ID: 17160276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in the design of antimicrobial peptide conjugates.
    Silva ARP; Guimarães MS; Rabelo J; Belén LH; Perecin CJ; Farías JG; Santos JHPM; Rangel-Yagui CO
    J Mater Chem B; 2022 May; 10(19):3587-3600. PubMed ID: 35262120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Membrane targeting cationic antimicrobial peptides.
    Ciumac D; Gong H; Hu X; Lu JR
    J Colloid Interface Sci; 2019 Mar; 537():163-185. PubMed ID: 30439615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015).
    Kosikowska P; Lesner A
    Expert Opin Ther Pat; 2016 Jun; 26(6):689-702. PubMed ID: 27063450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut-Antimicrobial Peptides: Synergistic Co-Evolution with Antibiotics to Combat Multi-Antibiotic Resistance.
    Baindara P; Mandal SM
    Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial Peptides in Farm Animals: An Updated Review on Its Diversity, Function, Modes of Action and Therapeutic Prospects.
    Kumar R; Ali SA; Singh SK; Bhushan V; Mathur M; Jamwal S; Mohanty AK; Kaushik JK; Kumar S
    Vet Sci; 2020 Dec; 7(4):. PubMed ID: 33352919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.